Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$473.42 - $539.26 $27,458 - $31,277
-58 Reduced 0.91%
6,291 $3.38 Million
Q4 2023

Jan 25, 2024

BUY
$437.42 - $470.64 $70,862 - $76,243
162 Added 2.62%
6,349 $2.94 Million
Q3 2023

Nov 01, 2023

SELL
$402.4 - $446.42 $184,701 - $204,906
-459 Reduced 6.91%
6,187 $2.69 Million
Q2 2023

Jul 31, 2023

SELL
$354.01 - $427.31 $124,257 - $149,985
-351 Reduced 5.02%
6,646 $2.84 Million
Q1 2023

May 02, 2023

SELL
$335.35 - $386.06 $25,821 - $29,726
-77 Reduced 1.09%
6,997 $2.49 Million
Q4 2022

Jan 30, 2023

BUY
$346.68 - $397.58 $11,093 - $12,722
32 Added 0.45%
7,074 $2.65 Million
Q3 2022

Nov 07, 2022

BUY
$321.25 - $373.84 $2.26 Million - $2.63 Million
7,042 New
7,042 $2.39 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $83.2B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Wakefield Asset Management Lllp Portfolio

Follow Wakefield Asset Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Wakefield Asset Management Lllp with notifications on news.